Global Non-recombinant Coagulation Factors Supply, Demand and Key Producers, 2023-2029

Global Non-recombinant Coagulation Factors Supply, Demand and Key Producers, 2023-2029

The global Non-recombinant Coagulation Factors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.

This report studies the global Non-recombinant Coagulation Factors production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Non-recombinant Coagulation Factors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-recombinant Coagulation Factors that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Non-recombinant Coagulation Factors total production and demand, 2018-2029, (K Units)

Global Non-recombinant Coagulation Factors total production value, 2018-2029, (USD Million)

Global Non-recombinant Coagulation Factors production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Non-recombinant Coagulation Factors consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Non-recombinant Coagulation Factors domestic production, consumption, key domestic manufacturers and share

Global Non-recombinant Coagulation Factors production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Non-recombinant Coagulation Factors production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Non-recombinant Coagulation Factors production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Non-recombinant Coagulation Factors market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical, Instituto Grifols SA, CSL Behring LLC, KM Biologics KK, Baxter Healthcare Corp., Sanquin, Johnson & Johnson, Octapharma AG and Bio Products Laboratory Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-recombinant Coagulation Factors market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Non-recombinant Coagulation Factors Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Non-recombinant Coagulation Factors Market, Segmentation by Type
Coagulation Factor VIII
Human Fibrinogen
Others

Global Non-recombinant Coagulation Factors Market, Segmentation by Application
Hemophilia
Fibrinogen Deficiency
Other

Companies Profiled:
Takeda Pharmaceutical
Instituto Grifols SA
CSL Behring LLC
KM Biologics KK
Baxter Healthcare Corp.
Sanquin
Johnson & Johnson
Octapharma AG
Bio Products Laboratory Ltd.
Grifols Biologicals, Inc.
Pfizer Inc.
Intas Biopharmaceuticals Ltd.
Shandong Taibang Biological Products
Sinopharm Group Shanghai Blood Products
SHANGHAI RAAS
China Resources Boya Bio-Pharmaceutical
Chengdu Rongsheng Pharmaceuticals
Yuanda Shuyang Pharmaceutical
HUALAN BIO

Key Questions Answered

1. How big is the global Non-recombinant Coagulation Factors market?

2. What is the demand of the global Non-recombinant Coagulation Factors market?

3. What is the year over year growth of the global Non-recombinant Coagulation Factors market?

4. What is the production and production value of the global Non-recombinant Coagulation Factors market?

5. Who are the key producers in the global Non-recombinant Coagulation Factors market?